News - North America

Filter

Current filters:

North America

Popular Filters

1830 to 1854 of 1898 results

Changing of the Guard begins in biotech sector

08-06-2011

The biotechnology sector is bracing for change this year as a flurry of "biosimilar" or "biogeneric"…

BiotechnologyGenericsMarkets & MarketingNorth AmericaRegulation

Battle for share of US $8.5 billion in vitro diagnostic market

08-06-2011

The US in-vitro diagnostic market, including immunochemistry, molecular diagnostics, point-of-care testing,…

Abbott LaboratoriesMarkets & MarketingNorth AmericaPharmaceuticalRoche

FDA accepts ciclesonide NDA from Nycomed partner Sunovion

07-06-2011

Swiss drugmaker Nycomed, the subject of a $13.7 billion takeover bid from Japan’s Takeda (TYO:4502;…

Ciclesonide Inhalation AerosolNorth AmericaNycomedPharmaceuticalRegulationRespiratory and PulmonarySunovion

Blow for Orexigen as regulatory demands see firm put obesity drug Contrave on hold

06-06-2011

Shares of US biotech firm Orexigen Therapeutics (Nasdaq: OREX) plunged 33% to $2.13 by afternoon trading…

ContraveMetabolicsNorth AmericaOrexigen TherapeuticsPharmaceuticalRegulation

Johnson & Johnson faces $327 million penalty over Risperdal marketing

06-06-2011

Civil penalties amounting to just over $327 million have been announced in the case of State of South…

Johnson & JohnsonLegalNeurologicalNorth AmericaOrtho-McNeil-JanssenPharmaceuticalRisperdal

US Biotech posts small gain in May, says Burrill

06-06-2011

It was a quiet month for US biotech with the Burrill Biotech Select Index recording a small 2.8% gain…

BiotechnologyFinancialNorth America

US FDA says use of ARBs for hypertension does not increase risk of cancer

03-06-2011

The US Food and Drug Administration stated yesterday that a group of drugs used to control high blood…

Cardio-vascularNorth AmericaPharmaceuticalRegulation

FDA denies Citizen Petition on generic Combivir 180-day exclusivity “First Applicant” issue

03-06-2011

Last week, in a seven-page response, the US Food and Drug Administration denied an October 18, 2010 Citizen…

CombivirGenericsLegalLupinNorth AmericaPatentsTeva Pharmaceutical Industries

Health Canada OKs AstraZeneca’s Brilinta and new use for Merck’s Gardasil

02-06-2011

Anglo-Swedish drug major AstraZeneca (LSE: AZN) says that Health Canada has approved Brilinta (ticagrelor…

AstraZenecaBrilintaCardio-vascularGardasilMerck & CoNorth AmericaOncologyPharmaceuticalRegulation

Progress Report 2011: Health care renewal in Canada

02-06-2011

A new report on Canada's health care performance, released this week by the Health Council of Canada,…

HealthcareNorth AmericaPharmaceutical

CBO Director reviews potential effects of a ban on DTC advertising of new Rx drugs in USA

01-06-2011

Direct-to-consumer (DTC) advertising of prescription drugs in the USA has elicited various concerns,…

Markets & MarketingNorth AmericaPharmaceuticalRegulation

MAP Pharma files NDA with US regulator for Levadex in migraine

31-05-2011

MAP Pharmaceuticals (Nasdaq: MAPP) has submitted a New Drug Application to the US Food and Drug Administration…

LevadexMAP PharmaceuticalsNeurologicalNorth AmericaPharmaceuticalRegulation

US FDA approves Optimer’s Dificid for C. difficile infection

31-05-2011

Following a positive advisory panel recommendation last month, the US Food and Drug Administration has…

Antibiotics and Infectious diseasesCubist PharmaceuticalsDificidNorth AmericaOptimer PharmaceuticalsPharmaceuticalRegulation

US GPhA calls on House Appropriations Committee to protect funding for FDA; welcomes Solicitor General’s action

30-05-2011

The USA’s Generic Pharmaceutical Association (GPhA) has written to House Appropriations Committee…

FinancialGenericsLegalNorth AmericaRegulation

Important implications of Abbott win in US patent ruling

30-05-2011

US health care major Abbott Laboratories (NYSE: ABT) last week won a US appeals court ruling that will…

Abbott LaboratoriesLegalNorth AmericaPatentsPharmaceutical

Amylin wins first round in squabble with Lilly over diabetes link with Boehringer

27-05-2011

In an initial win for US biotech firm Amylin Pharmaceuticals (Nasdaq: AMLN), the US District Court for…

AmylinBoehringer IngelheimDiabetesEli LillyExenatide InjectionLegallinagliptinNorth AmericaPharmaceuticalTradjenta

Canada’s Quebec Province overhauls cancer drug evaluation

27-05-2011

The Canadian Province of Quebec, which has the highest incidence of new cancer cases in the country,…

North AmericaPharmaceuticalRegulation

Major stakeholders optimistic about future of drug development, but differ on defining value

27-05-2011

Biopharmaceutical executives, managed care executives, physicians and patients with chronic illness foresee…

HealthcareNorth AmericaPharmaceuticalResearch

US Senators accuse Sanofi over lobbying FDA on generic Lovenox

26-05-2011

US Senate Finance Committee Chairman Max Baucus (Democrat, Montana) and senior Committee Member Chuck…

Cardio-vascularGenericsLovenoxNorth AmericaPharmaceuticalRegulationSanofi

US Presidential visit to UK underlines cooperation in science, innovation and higher education

26-05-2011

The joint statement agreed yesterday by UK Prime Minister David Cameron and US President Barack Obama,…

EuropeJohnson & JohnsonNorth AmericaPharmaceuticalResearch

FTC Files Amicus Brief with US Appeals Court to reverse pay-for-delay ruling

25-05-2011

Continuing its battle against pay-for-delay between drug originators and generic makers, the US Federal…

GenericsLegalMerck & CoNorth AmericaPatentsPharmaceuticalSchering-Plough

1830 to 1854 of 1898 results

Back to top